Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
National Institutes of Health · Department of Health and Human Services · RFA-HL-26-018
In plain English
National Institutes of Health (Department of Health and Human Services) is accepting applications for this grant until Dec 23, 2027 (407 days left).
The listing does not state award amounts or the number of awards.
Eligible applicant types include nonprofits, small businesses, for-profit companies, state governments, local governments, tribal governments & organizations, colleges & universities, school districts and public housing authorities, plus others described in the listing.
The listing says cost sharing or matching is not required.
Built only from the fields in the Grants.gov listing. Always confirm on the official listing.
Key facts
| Status | Posted: open for applications |
|---|---|
| Close date | Dec 23, 2027 · 407 days left |
| Posted date | Nov 22, 2024 |
| Opportunity number | RFA-HL-26-018 |
| Agency | National Institutes of Health (Department of Health and Human Services) |
| Funding instrument | Grant |
| Category | Health |
| Opportunity category | Discretionary |
| Award ceiling (max per award) | Not stated |
| Award floor (min per award) | Not stated |
| Estimated total program funding | Not stated |
| Expected number of awards | Not stated |
| Cost sharing or matching required | No |
| Assistance listing (CFDA/ALN) | 93.233 – National Center on Sleep Disorders Research 93.837 – Cardiovascular Diseases Research 93.838 – Lung Diseases Research 93.839 – Blood Diseases and Resources Research 93.855 – Allergy and Infectious Diseases Research |
| Last updated on Grants.gov | Apr 29, 2026 |
| Archive date | Jan 28, 2028 |
Who can apply
Browse similar: Nonprofits · Small businesses · For-profit companies · State governments · Local governments · Tribal governments & organizations · Colleges & universities · School districts · Public housing authorities
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Native American tribal governments (federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than federally recognized tribal governments)
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others (see the eligibility details in the listing)
Additional eligibility information (excerpt from the listing):
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. …
Description
Excerpt from the official synopsis on Grants.gov (shortened; read the full text on the official listing):
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. This specific Catalyze Product Definition initiative will provide the early stage translational support needed for the activities required to identify and characterize potential therapeutic candidates and combination products to treat HLBS diseases and disorders. This initiative has a companion initiative that supports development of devices and diagnostics and is also part of a suite of innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical Program.
Read the full listing on Grants.gov → · Agency's announcement page
More Department of Health and Human Services grants closing soon
All →- 2days leftNCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
More health grants closing soon
All →- 5days leftEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 6days leftSingle Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftPrevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftFeasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth